Drugs / Sogyeonghwalhyeol-tang
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT03132974 | Sep 2018 → Dec 2021 | chronic pain syndrome | Gachon University Gil Oriental Medical Hospital | Unknown | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT02988232 | Jul 2016 → Dec 2020 | — | Gachon University Gil Oriental Medical Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sogyeonghwalhyeol-tang | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02988232 ↗ |
| Known as | SGHH | “This study aims to evaluate the clinical efficacy and safety of herbal medicine, Sogyeonghwalhyeol-tang (SGHH) on work related chronic low back pain patients.” PMID 32791704 ↗ Jul 2020 |
| Modality | Traditional medicine (herbal / TCM) | “herbal extract” NCT02988232 ↗ |